Evaluation of Pharmaceutical Quality of Conventional Dosage Forms Containing Paracetamol and Caffeine Available in the Turkish Drug Market

The aim of this study was to evaluate the quality of conventional paracetamol- (PA) and caffeine- (CA) containing combined dosage forms in the Turkish drug market. For this purpose, weight variation, content uniformity, diameter and thickness, hardness, friability, disintegration, and dissolution tests were carried out. Content uniformity and dissolution tests were performed by a validated high-performance liquid chromatography (HPLC) method. Separations were carried on an ACE 5-C18, 5-µm LC column (250 × 4.6 mm) using isocratic elution with a methanol/water (40:60 v/v) mobile phase. The injection volume was 20 μL, and UV detection was performed at 270 nm. The weight variation results were in accordance with content uniformity results. All dosage forms fulfilled the USP requirement of not less than 75% of active ingredients of the labeled claim dissolved within 60 min. Also, all tablets met the rapidly dissolving criterion (more than 85% of the labeled amount of the drug substance dissolved within 30 min). The results of this study indicate that PA- and CA-containing conventional dosage forms available in the Turkish drug market pass all the established quality control tests successfully, and they can be used interchangeably.

[1]  M. Doherty,et al.  Paracetamol: not as safe as we thought? A systematic literature review of observational studies , 2015, Annals of the rheumatic diseases.

[2]  M. Salem,et al.  Quality in the pharmaceutical industry – A literature review , 2013, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[3]  R. Thornhill,et al.  Background and Overview of the Book , 2014 .

[4]  Tudor I. Oprea,et al.  BDDCS Applied to Over 900 Drugs , 2011, The AAPS Journal.

[5]  Leslie Z. Benet,et al.  The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs , 2009, Pharmaceutical Research.

[6]  M. W. Dong,et al.  Handbook Of Pharmaceutical Analysis By Hplc , 2008 .

[7]  S. Sahin,et al.  Comparison of Dissolution Profiles of Two Commercially Available Co-Trimoxazole Tablets , 2008 .

[8]  D. Barends,et al.  Biowaiver monographs for immediate release solid oral dosage forms: acetaminophen (paracetamol). , 2006, Journal of pharmaceutical sciences.

[9]  B. Mcgowan,et al.  Usage of paracetamol-containing combination analgesics remains high in primary care. , 2005, British journal of clinical pharmacology.

[10]  Lu Wang-bo Simultaneous determination of paracetamol and caffeine in human plasma by HPLC , 2005 .

[11]  Christos Reppas,et al.  Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.

[12]  E. Forgács,et al.  Validation and simultaneous determination of paracetamol and caffeine in pharmaceutical formulations by RP-HPLC , 2003 .

[13]  D. Agbaba,et al.  HPLC assay of acetylsalicylic acid, paracetamol, caffeine and phenobarbital in tablets. , 2002, Farmaco.

[14]  M. Altun HPLC Method for the Analysis of Paracetamol, Caffeine and Dipyrone , 2002 .

[15]  Michael Levin Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System , 2001 .

[16]  K. M. Emara,et al.  Determination of phenyltoloxamine salicylamide, caffeine, paracetamol, codeine and phenacetin by HPLC. , 1989, Talanta.